Temporary Setbacks At BioLife

  • One of its acquired companies, Sterling, could not cope with the rapidly rising demand and this generated substantial one-off costs, marring the figures.
  • However, underlying growth is very healthy, better actually than we expected.
  • While the shares are still not cheap, they are a lot cheaper than they were even recently.
  • When the problems are ironed out we think the shares can recover, although keep in mind this is a treacherous market.
  • Looking for more investing ideas like this one? Get them exclusively at SHU Growth Portfolio. Learn More »